Owner Janssen Pharmaceutica N.V.

Inventors Giethlen, Bruno; Schoentjes, Bruno; Csoka, Imre Christian Francis; Meyer, Christophe; Joubert, Muriel; Wermuth, Camille Georges; Ligny, Yannick Aime Eddy; Van Hijfte, Luc; Lacrampe, Jean Fernand Armand; Arts, Janine; Contreras, Jean-Marie

Agent Shelston IP

Pub. Number AU-B-2005286525

PCT Pub. Number WO2006/032631

Priority 04077630.4 22.09.04 EP; 60/613,902 28.09.04 US

Filing date 16 September 2005

Wipo publication date 30 March 2006

Acceptance publication date 16 June 2011

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/4439 (2006.01)

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61K 31/501 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups